Categories
Connect with us on LinkedIn
From Months to Hours: MMC’s 5-Hour EDC Builds
Discover how a specialized CRO delivers first-in-human device studies at speed with Castor
Castor Catalyst: Launching Self-Driving Clinical Trials with Google Cloud AI
Castor has launched Castor Catalyst, an innovative AI-powered platform developed in collaboration with Google Cloud. Built on Google's...
Better Evidence Starts with Better Infrastructure
Join Castor at ISPOR Europe 2025 | November 9–12 | Glasgow, Scotland
Castor is attending ISPOR Europe 2025 in Glasgow to showcase smarter, faster approaches to real-world evidence. Join us...
Castor Catalyst
See how Castor Catalyst automates the transformation of real-world data into submission-ready study datasets. In this on-demand demo,...
Automated Evidence Generation for Regulatory-Grade Real-World Data
Manual data abstraction can’t keep up with new FDA and EMA RWE standards. This whitepaper explains how automated...
The EMR Interoperability Dream vs. Clinical Research Reality
A Practical Guide to the 21st Century Cures Act, FHIR Data, and Bridging the Gap for Audit-Ready Evidence
Discover the real-world challenges of EMR interoperability in clinical research. Learn how the 21st Century Cures Act, FHIR...
From PDFs to Precision: Castor Powers Up RWE in San Diego
Join Castor at DIA’s Real-World Evidence Conference | Oct 16–17 | The Westin San Diego Bayview
Join Castor in San Diego for DIA’s Real-World Evidence Conference 2025, where we’ll be launching Castor Catalyst, our...
From Gaudí to Global Deployment: Castor Builds Smarter Trials in Barcelona
Join Castor at SCOPE Europe | Oct 14–15 | InterContinental Barcelona (Fira Center)
Castor is heading to SCOPE Europe 2025 in Barcelona to showcase how sponsors can streamline global clinical trial...
On-site ePRO in Action: A Recap of Castor’s Product Spotlight
Castor’s on-site ePRO adds in-clinic PRO capture to the ePRO/CDMS workflow you already use. Staff use a site...
ICH GCP E6(R3) Implementation: Practical Approaches and Real-World Considerations
ICH GCP E6(R3) implementation requires strategic planning beyond basic compliance. This practical guide covers realistic 12-18 month timelines,...
Decentralized Clinical Trial Platforms in 2025: A Practical Guide for Clinical Operations
DCT platform evaluation guide: integration strategies, vendor comparison, implementation timelines for clinical operations teams.
On-site ePRO
Castor’s On-site ePRO ensures higher flexibility for both study designers and participants, by maximizing opportunities for data capture.
Castor On-site ePRO
Download our On-site ePRO factsheet to view an overview of our services.
EQ-5D in European Trials: When Generic QoL Measures Actually Matter
Analysis of 735 FDA drug approvals reveals 0% EQ-5D labeling inclusion, while European HTA bodies demonstrate 18% technology...
Castor Product Spotlight: New On-site ePRO
Watch this on-demand Product Spotlight to see Castor’s On-site ePRO in action. Our experts show how on-site capture...
Navigating the eCOA Vendor Landscape: What Clinical Teams Really Need to Know
The eCOA market reached $2.27 billion in 2025 with 16.1% projected growth, yet vendor selection remains critical for...
Optimizing eCOA in Oncology Trials: Patient-Focused Data Capture for Cancer Research
Oncology leads clinical innovation with 7,747 trials registered through 2022, yet only 7% of cancer patients participate. This...
ePRO, eCOA 101: Everything You Need to Know About ePRO and eCOA
Electronic Clinical Outcome Assessment (ECOA) and electronic Patient Reported Outcomes (ePRO) represent far more than digital surveys in...
Connect with us on LinkedIn
